Arch_Twitter_Logo.png
Arch Therapeutics Launches Experts in Wound Care Program
18 oct. 2021 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch_Twitter_Logo.png
Arch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities
02 sept. 2021 07h00 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch_Twitter_Logo.png
Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021
07 juil. 2021 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
Arch_Twitter_Logo.png
Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021
02 juin 2021 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
Arch_Twitter_Logo.png
Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS)
10 mai 2021 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, presents...
Arch_Twitter_Logo.png
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)
27 avr. 2021 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...